Kyle J. Comishen , Meha Bhatt , Katie Yeung , Jehan Irfan , Ayesha Zia , Robert F. Sidonio Jr. , Paula James
{"title":"青少年和成人患者大量月经出血的病因和诊断:文献的系统回顾和荟萃分析。","authors":"Kyle J. Comishen , Meha Bhatt , Katie Yeung , Jehan Irfan , Ayesha Zia , Robert F. Sidonio Jr. , Paula James","doi":"10.1016/j.jtha.2024.11.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Heavy menstrual bleeding (HMB) is excessive menstrual blood loss that interferes with an individual’s quality of life. Many individuals with HMB are inadequately managed by health care providers.</div></div><div><h3>Objectives</h3><div>This systematic review aims to provide a comprehensive summary of the etiologies and diagnosis of HMB while calculating the prevalence of underlying causes among premenopausal patients and quantifying the test accuracy of diagnostic strategies.</div></div><div><h3>Methods</h3><div>MEDLINE, EMBASE, the Cochrane Library, and Web of Science were searched since inception to include studies investigating the prevalence of underlying etiology and diagnostic accuracy of investigations for HMB. The primary outcome was the prevalence of the causes of HMB, secondary outcome included the prevalence of etiology by age. Meta-analyses were conducted via random-effects model.</div></div><div><h3>Results</h3><div>In total, 53 studies were included. Forty-five studies included data on the prevalence of underlying HMB etiology, totaling 41 541 patients. The overall prevalence of bleeding disorders was 30% (95% CI, 14-46); von Willebrand disease, 8% (95% CI, 7-10); platelet function defect, 9% (95% CI, 7-12); abnormal thyroid, 3% (95% CI, 0-6); and polycystic ovarian syndrome, 8% (95% CI, 4-12). Subgroup analysis showed bleeding disorders were prevalent in 16% (95% CI, −8 to 41) of adults with HMB but in 39% (95% CI 18-60) of adolescents with HMB.</div></div><div><h3>Conclusion</h3><div>Many diagnoses were associated with bleeding disorders and, therefore, warrant investigation when assessing a patient with HMB of unknown etiology. The causes are likely age dependent and should be considered when diagnosing HMB.</div></div>","PeriodicalId":17326,"journal":{"name":"Journal of Thrombosis and Haemostasis","volume":"23 3","pages":"Pages 863-876"},"PeriodicalIF":5.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature\",\"authors\":\"Kyle J. Comishen , Meha Bhatt , Katie Yeung , Jehan Irfan , Ayesha Zia , Robert F. Sidonio Jr. , Paula James\",\"doi\":\"10.1016/j.jtha.2024.11.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Heavy menstrual bleeding (HMB) is excessive menstrual blood loss that interferes with an individual’s quality of life. Many individuals with HMB are inadequately managed by health care providers.</div></div><div><h3>Objectives</h3><div>This systematic review aims to provide a comprehensive summary of the etiologies and diagnosis of HMB while calculating the prevalence of underlying causes among premenopausal patients and quantifying the test accuracy of diagnostic strategies.</div></div><div><h3>Methods</h3><div>MEDLINE, EMBASE, the Cochrane Library, and Web of Science were searched since inception to include studies investigating the prevalence of underlying etiology and diagnostic accuracy of investigations for HMB. The primary outcome was the prevalence of the causes of HMB, secondary outcome included the prevalence of etiology by age. Meta-analyses were conducted via random-effects model.</div></div><div><h3>Results</h3><div>In total, 53 studies were included. Forty-five studies included data on the prevalence of underlying HMB etiology, totaling 41 541 patients. The overall prevalence of bleeding disorders was 30% (95% CI, 14-46); von Willebrand disease, 8% (95% CI, 7-10); platelet function defect, 9% (95% CI, 7-12); abnormal thyroid, 3% (95% CI, 0-6); and polycystic ovarian syndrome, 8% (95% CI, 4-12). Subgroup analysis showed bleeding disorders were prevalent in 16% (95% CI, −8 to 41) of adults with HMB but in 39% (95% CI 18-60) of adolescents with HMB.</div></div><div><h3>Conclusion</h3><div>Many diagnoses were associated with bleeding disorders and, therefore, warrant investigation when assessing a patient with HMB of unknown etiology. The causes are likely age dependent and should be considered when diagnosing HMB.</div></div>\",\"PeriodicalId\":17326,\"journal\":{\"name\":\"Journal of Thrombosis and Haemostasis\",\"volume\":\"23 3\",\"pages\":\"Pages 863-876\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thrombosis and Haemostasis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1538783624007049\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1538783624007049","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:大量月经出血(HMB)是指月经失血过多,影响个体的生活质量。许多HMB患者没有得到医疗保健提供者的充分管理。本系统综述旨在全面总结HMB的病因和诊断,同时计算绝经前患者潜在病因的患病率,并量化诊断策略的检测准确性。方法:MEDLINE, EMBASE, Cochrane图书馆和Web of Science自成立以来进行检索,包括调查HMB潜在病因的患病率和调查诊断准确性的研究。主要结局是HMB病因的患病率,次要结局包括按年龄划分的病因患病率。采用随机效应模型进行meta分析。结果:纳入53项研究。45项研究纳入了HMB潜在病因的患病率数据,共计41541例患者。出血性疾病的总体患病率为30% [95% CI 14-46],血管性血液病(VWD)为8% [95% CI 7-10],血小板功能缺陷(PFD)为9% [95% CI 7-12],甲状腺异常3% [95% CI 0-6],多囊卵巢综合征(PCOS)为8% [95% CI 4-12]。亚组分析显示,16% [95% CI -8-41]的成人HMB患者普遍存在出血性疾病,而39% [95% CI 18-60]的青少年HMB患者普遍存在出血性疾病。结论:许多诊断与出血性疾病有关,因此,在评估病因不明的HMB患者时,需要进行调查。病因可能与年龄有关,在诊断HMB时应予以考虑。
Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature
Background
Heavy menstrual bleeding (HMB) is excessive menstrual blood loss that interferes with an individual’s quality of life. Many individuals with HMB are inadequately managed by health care providers.
Objectives
This systematic review aims to provide a comprehensive summary of the etiologies and diagnosis of HMB while calculating the prevalence of underlying causes among premenopausal patients and quantifying the test accuracy of diagnostic strategies.
Methods
MEDLINE, EMBASE, the Cochrane Library, and Web of Science were searched since inception to include studies investigating the prevalence of underlying etiology and diagnostic accuracy of investigations for HMB. The primary outcome was the prevalence of the causes of HMB, secondary outcome included the prevalence of etiology by age. Meta-analyses were conducted via random-effects model.
Results
In total, 53 studies were included. Forty-five studies included data on the prevalence of underlying HMB etiology, totaling 41 541 patients. The overall prevalence of bleeding disorders was 30% (95% CI, 14-46); von Willebrand disease, 8% (95% CI, 7-10); platelet function defect, 9% (95% CI, 7-12); abnormal thyroid, 3% (95% CI, 0-6); and polycystic ovarian syndrome, 8% (95% CI, 4-12). Subgroup analysis showed bleeding disorders were prevalent in 16% (95% CI, −8 to 41) of adults with HMB but in 39% (95% CI 18-60) of adolescents with HMB.
Conclusion
Many diagnoses were associated with bleeding disorders and, therefore, warrant investigation when assessing a patient with HMB of unknown etiology. The causes are likely age dependent and should be considered when diagnosing HMB.
期刊介绍:
The Journal of Thrombosis and Haemostasis (JTH) serves as the official journal of the International Society on Thrombosis and Haemostasis. It is dedicated to advancing science related to thrombosis, bleeding disorders, and vascular biology through the dissemination and exchange of information and ideas within the global research community.
Types of Publications:
The journal publishes a variety of content, including:
Original research reports
State-of-the-art reviews
Brief reports
Case reports
Invited commentaries on publications in the Journal
Forum articles
Correspondence
Announcements
Scope of Contributions:
Editors invite contributions from both fundamental and clinical domains. These include:
Basic manuscripts on blood coagulation and fibrinolysis
Studies on proteins and reactions related to thrombosis and haemostasis
Research on blood platelets and their interactions with other biological systems, such as the vessel wall, blood cells, and invading organisms
Clinical manuscripts covering various topics including venous thrombosis, arterial disease, hemophilia, bleeding disorders, and platelet diseases
Clinical manuscripts may encompass etiology, diagnostics, prognosis, prevention, and treatment strategies.